Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Juvenile Arthritis Clinical Trials
Juvenile Arthritis clinical trials are recruiting across 14 cities. Here are the cities with the most active studies:
Juvenile Arthritis Trial Phases
5 research organizations are sponsoring juvenile arthritis trials.
About Juvenile Arthritis
Juvenile idiopathic arthritis (JIA) is the most common type of arthritis in children, causing joint inflammation, pain, and stiffness. It encompasses several subtypes with varying patterns. Treatment includes NSAIDs, DMARDs, biologics, and physical therapy.
Clinical trials are advancing new treatments for juvenile arthritis. Currently, 5 studies are recruiting a combined 1,320 participants across the United States. Research is being conducted by 5 organizations including Children's Hospital Medical Center, Cincinnati, Duke University, Washington University School of Medicine and 2 others.
2026 Juvenile Arthritis Research Landscape
As of July 2026, the juvenile arthritis clinical trial landscape includes 5 actively recruiting studies across 14 cities in the United States. These studies are collectively seeking 1,320 participants, with an average enrollment target of 264 per study.
The research spans multiple phases of development: 2 studies are in PHASE3, 1 study is in NA. The presence of Phase 3 trials indicates that some juvenile arthritis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 5 different organizations, including Children's Hospital Medical Center, Cincinnati, Duke University, Washington University School of Medicine, Children's National Research Institute, AbbVie.
Geographically, juvenile arthritis trials are most concentrated in Cincinnati, Ohio (2 trials); Columbus, Ohio (2 trials); Washington D.C., District of Columbia (2 trials); San Francisco, California (1 trial); Gainesville, Florida (1 trial) and 7 other cities.
Featured Juvenile Arthritis Studies
Highlighted recruiting studies for juvenile arthritis, selected by enrollment size and research scope.
The BRIDGE Pain Study
The purpose of the study is to discover at least two distinct Musculoskeletal pain subtypes. These types are caused by different brain-and-immune system signals that affect how the body feels pain, and they are also shaped by a person's biology, psychology, and social environment. Aim 1. We want to sort adolescents and young adults with long lasting muscle and bone pain into two different groups....
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
This study is an open-label, randomized, multicenter trial that incorporates a multi-arm design comparing each of 3 non-TNFi (Tumor Necrosis Factor inhibitor) medications to a second TNFi (active control) within a sequential multiple assignment randomized trial design with 2 randomization stages corresponding with clinical decision points. The first randomization addresses whether each of the 3 no...
Pain in Juvenile Arthritis
Juvenile idiopathic arthritis (JIA) is the most common rheumatologic disease in children. The main symptoms of JIA, which are often the primary focus of treatment, include joint swelling, stiffness, and tenderness. Additional symptoms can include malaise, fatigue, and pain. However, the exact mechanisms contributing to pain are not yet fully understood. Participants will complete a 2.5-hours study...
Frequently Asked Questions About Juvenile Arthritis Clinical Trials
Are there juvenile arthritis clinical trials near me?
Yes, there are 5 juvenile arthritis clinical trials currently recruiting across 14+ cities in the United States, including Cincinnati, Ohio; Columbus, Ohio; Washington D.C., District of Columbia. Browse the studies above to find one at a location convenient for you.
How do I join a juvenile arthritis clinical trial?
To join a juvenile arthritis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are juvenile arthritis clinical trials free?
Yes, participation in juvenile arthritis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of juvenile arthritis treatments are being studied?
Current juvenile arthritis clinical trials are testing a range of approaches across PHASE3 (2 studies), NA (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 5 research organizations.
Is it safe to participate in juvenile arthritis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov